SpyGlass Pharma SGP
NASDAQ SGP
$26.50 +0.50 (+1.92%)
As of: Oct 1, 2026 · 3:38 PM EDT

SpyGlass Pharma (SGP) Preferred Stock Liabilities (2024 - 2025)

Updated

SpyGlass Pharma's Preferred Stock Liabilities was $204.54 million in Q4 2025, up 181.9% from $72.55 million a year earlier.

Analysis

SpyGlass Pharma (SGP) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

  • In earlier years, Preferred Stock Liabilities was $72.55 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 SpyGlass Pharma 869.60 Mn 869.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 204.54 Mn
Jun 30, 2025 204.54 Mn
Dec 31, 2024 72.55 Mn
API Access

SpyGlass Pharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SGP&period=max&api_key=YOUR_API_KEY